The recently described clinical spectrum for FAD synthase deficiency has ranged from neonatal-onset, a lethal disease with metabolic myopathy, cardiomyopathy, swallowing, speech difficulties, and respiratory insufficiency, to later-onset, a potentially treatable neuromuscular disorder with lipid storage myopathy, MADD-like metabolic aberrations, and combined respiratory-chain deficiency [34]
It can also aid in weight loss and improve heart health by reducing cholesterol levels
This narrative review summarizes the preclinical and clinical studies investigating the capacity of GLP-1R agonists as therapeutic agents for DPN
Guter Kundenservice, antwortet innerhalb von 24 Stunden
The presence of resveratrol in red wine was initially thought to be responsible for red wines beneficial cardiovascular effects
BNF NICE